Multiple Sclerosis
Multiple Sclerosis
Multiple Sclerosis
Definition
Multiple sclerosis (MS) is a chronic, potentially debilitating disease that affects your
central nervous system, which is made up of your brain and spinal cord. Multiple
sclerosis is widely believed to be an autoimmune disease, a condition in which your
immune system attacks components of your body as if they're foreign.
In multiple sclerosis, the body mistakenly directs antibodies and white blood cells
against proteins in the myelin sheath, a fatty substance that insulates nerve fibers in
your brain and spinal cord. This results in inflammation and injury to the sheath and
ultimately to the nerves that it surrounds. The result may be multiple areas of scarring
(sclerosis). Eventually, this damage can slow or block the nerve signals that control
muscle coordination, strength, sensation and vision.
Multiple sclerosis affects an estimated 300,000 people in the United States and
probably more than 1 million people around the world — including twice as many
women as men. Most people experience their first signs or symptoms between ages 20
and 40.
Symptoms
Signs and symptoms of multiple sclerosis vary widely, depending on the location of
affected nerve fibers. Multiple sclerosis symptoms may include:
In some cases, people with multiple sclerosis may also develop muscle stiffness or
spasticity, slurred speech, paralysis, or problems with bladder, bowel or sexual
function. Mental changes, such as forgetfulness or difficulties with concentration, also
may occur.
Causes
Your central nervous system contains millions of nerve cells that send their electrical
signals to and from your brain along wire-like extensions of the cells called axons, or
nerve fibers. Myelin is the fatty substance that coats and protects these fibers, similar
to the way insulation shields electrical wires.
In people with multiple sclerosis, the immune system mistakenly destroys the cells
that produce the myelin sheath. As a result, myelin becomes inflamed and swollen
and detaches from the nerve fibers. The detached myelin may eventually be
destroyed. Firm or hardened (sclerosed) patches of scar tissue form over the fibers.
When nerve impulses reach a damaged area, some impulses are blocked or delayed
from traveling to or from your brain. Ultimately, this process leads to degeneration of
the nerves themselves, which likely accounts for the permanent disabilities that may
develop in MS.
Doctors and researchers don't understand what causes this autoimmune reaction.
Something seems to trigger the condition in susceptible people.
Genetic factors may make certain people more susceptible to multiple sclerosis. But
genetic susceptibility is only part of the explanation. A number of researchers believe
the disorder is related to a protein that mimics the myelin protein, which may be
introduced into the body by a virus. Other researchers believe that the immune system
overreacts toward myelin proteins in people with MS, which leads to an abnormal
tendency to develop autoimmune disease.
Patterns of MS
Whatever the multiple sclerosis cause or trigger, the disease occurs in four main
patterns:
Relapsing remitting. This type of multiple sclerosis is characterized by clearly defined flare-
ups, followed by periods of remission. The flare-ups typically appear suddenly, last a few
weeks or months, and then gradually disappear. Most people with MS have this form at the
time of diagnosis.
Primary progressive. People with this less common form of multiple sclerosis experience a
gradual decline, without periods of remission. People with this form of MS are usually older
than 40 when signs or symptoms begin.
Secondary progressive. More than half the people with relapsing remitting MS eventually
enter a stage of continuous deterioration referred to as secondary progressive MS. Sudden
relapses may occur, superimposed upon the continuous deterioration that characterizes this
type of multiple sclerosis.
Progressive relapsing. This is primary progressive MS with the addition of sudden episodes
of new symptoms or worsened existing ones. This form is relatively uncommon.
Risk factors
These factors may increase your risk of developing multiple sclerosis:
Medical history. Your doctor reviews your signs and symptoms and their
pattern.
Neurological examination. This examination systematically tests various
parts of your nervous system, including your reflexes, muscle strength, muscle
tone, and sensations of pain, heat, touch and vibration. Your doctor may also
observe your gait, posture, coordination and balance, and ask you questions to
help determine the clarity of your thinking, judgment and memory.
Magnetic resonance imaging (MRI) scan. The cylinder-shaped MRI scanner
creates tissue-slice images on a computer from data generated by a powerful
magnetic field and radio waves. Your doctor can view these images from any
direction or plane.
This imaging technique may reveal MS lesions, which are caused by myelin
loss. An intravenous dye, gadolinium, will highlight "active" lesions that have
developed within the past two months and this may help doctors know
whether the MS is in an active phase, even if no symptoms are present
indicating an attack of MS. Newer MRI techniques can provide even greater
detail about the degree of nerve fiber injury or permanent myelin loss and
recovery.
If you use Betaseron, you inject yourself under your skin (subcutaneously)
every other day. If you use Rebif, you inject yourself subcutaneously three
times a week. You self-inject Avonex into your muscle (intramuscularly) once
a week. These medications reduce but don't eliminate flare-ups of multiple
sclerosis. It's uncertain which of their many actions lead to a reduction in
disease activity and what their long-term benefits are. Beta interferons aren't
used in combination with one another; only one of these medications is used at
a time.
The Food and Drug Administration (FDA) has approved beta interferons only
for people with relapsing forms of MS who can still walk. Beta interferons
don't reverse damage and haven't been proved to significantly alter long-term
development of permanent disability. Some people develop antibodies to beta
interferons, which may make them less effective. Other people can't tolerate
the side effects, which may include symptoms similar to those of the flu
(influenza).
Doctors generally recommend beta interferons for people who have more than
one attack of MS a year and for those who don't recover well from flare-ups.
The treatment may also be used for people who have a significant buildup of
new lesions as seen on an MRI scan, even when there may not be major new
symptoms of disease activity.
The FDA has approved the use of several beta interferons for people who've
experienced a single attack that suggests multiple sclerosis, and who may be at
risk of future attacks and developing definite MS. Risk of MS may also be
suggested when an MRI scan of the brain shows lesions that predict a high risk
of conversion to definite MS. Controversy exists as to whether these people
should take these expensive and often inconvenient drugs for indefinite
periods, especially because some people do well both in the short term and
long term without therapy. Some doctors prefer to observe people at high risk
with follow-up examinations and MRI scans to document any ongoing
inflammatory disease activity before recommending long-term therapies such
as beta interferon.
During clinical trials, this drug was shown to significantly reduce the
frequency of attacks in people with relapsing MS. After receiving FDA
approval, however, the drug was withdrawn from the market because of
reports from three people who developed a rare, often fatal, brain disorder
called progressive multifocal leukoencephalopathy.
In 2006, after reconsideration of the drug's benefits for people with multiple
sclerosis, the FDA agreed to allow the drug to be marketed again under
specific conditions. Chief among these conditions is the requirement that
doctors, pharmacists and patients be involved in a special distribution program
known as TOUCH in order to prescribe, dispense or receive the drug. Because
of the drug's risks, it's generally recommended only for people whose
condition hasn't responded to other forms of MS therapy. Furthermore, there
has been no study direct comparing natalizumab to existing treatments to
prove whether it's superior to existing treatments.
Mitoxantrone may cause serious side effects, such as heart damage, after long-
term use, so it's typically not used for longer than two to three years. And it's
typically reserved for people with severe attacks or rapidly advancing disease
who don't respond to other treatments. Close monitoring is critical for anyone
on this medication.
Replacing your plasma may dilute the activity of the destructive factors in
your immune system, including antibodies that attack myelin, and help you to
recover. Plasma exchange has no proven benefit beyond three months from the
onset of the neurological symptoms.
If multiple sclerosis impairs your ability to do things you enjoy, talk with your doctor
about possible ways to get around the obstacles.
Remember that your physical health can directly impact your mental health. Denial,
anger and frustration are not uncommon when you learn life has dealt you something
painful and unexpected. Professionals such as therapists or behavioral psychologists
may help you put things in perspective. They can also teach you coping skills and
relaxation techniques that may be helpful.
Sometimes, joining a support group, where you can share experiences and feelings
with other people, is a good approach. Ask your doctor what support groups are
available in your community.
Many chronic illnesses, including multiple sclerosis, are associated with an increased
risk of depression. This isn't a failure to cope. Rather, depression may indicate a
disruption in the body's neurochemistry that can be helped with appropriate medical
treatment.
If you have a chronic illness, such as MS, there's no denying that it affects your life.
But how much you allow it to determine the quality of your life depends, to some
extent, on the way you choose to live day to day.